Senior insider sale
SVP, Head of Res./Clin. Dev. at ABEONA THERAPEUTICS INC. — senior position signals high conviction
$775.3K
124.31K shares
What this filing means
SESHADRI VISHWAS plans to sell 124.31K shares of ABEONA THERAPEUTICS INC. valued at approximately $775.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/9/2026ACC: 0001972481-26-000232
Officer· SVP, Head of Res./Clin. Dev.
Since Jun 2021
124.31K
Shares to sell
$775.3K
Approx. market value
141.33K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Awards
Equity Compensation
7/8/2026
141.33KTotal acquired141.33K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/8/2026 | Restricted Stock Awards Equity Compensation | 141.33K | — |
| Total | 141.33K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
31.92K
Market value
$169.3K
6/9/2026
—Completed
Units to sell
24.43K
Market value
$132.6K
6/8/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
67.97K
Market value
$473.3K
7/9/2026
Total
Units
124.31K
Value
$775.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/9/2026 | 31.92K | $169.3K | — | Completed |
6/8/2026 | 24.43K | $132.6K | — | Completed |
| Planned — Approximate Date | ||||
7/9/2026 | 67.97K | $473.3K | Nasdaq | Planned |
| Total | 124.31K | $775.3K | ||